ACC.26 Día 2 (Parte 2)

En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este segundo día en el ACC 2026 de Nueva Orleans. 1. Redo-Surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial 2. Transcatheter Aortic Valve Implantation Without Routine Percutaneous Coronary Intervention: A Randomized Controlled Trial 3. Protect The Head To Head Trial: Randomized Comparison of Emboliner Embolic Protection Catheter Vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement 4. Two-Year Outcomes After Transcatheter Tricuspid Repair Without Cross-over in the Randomized Tri-fr Trial 5. Spironolactone in the Treatment of Heart Failure (SPIRIT-HF)